Page last updated: 2024-08-25

acamprosate and Depression

acamprosate has been researched along with Depression in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	3 (37.50)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Minozzi, S; Rösner, S; Saulle, R	1
Aguiar, FS; Choi, DS; Hinton, DJ; Ho, AM; Jia, YF; Karpyak, VM; Qiu, Y; Weinshilboum, RM	1
Brady, KT; Brown, DG; Chiuzan, C; DeSantis, SM; Prisciandaro, JJ; Tolliver, BK	1
Pałucha-Poniewiera, A; Pilc, A	1
Helwig, H; Jahn, H; Kiefer, F; Otte, C; Tarnaske, T; Wiedemann, K	1
Roesner, S; Soyka, M	1
Swift, RM	1
Kranzler, HR; Van Kirk, J	1

Reviews

4 review(s) available for acamprosate and Depression

Article	Year
Baclofen for alcohol use disorder. The Cochrane database of systematic reviews, 2018, Nov-26, Volume: 11 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Craving; Depression; Female; GABA-B Receptor Agonists; Humans; Male; Middle Aged; Patient Dropouts; Randomized Controlled Trials as Topic; Recurrence	2018
New pharmacological approaches for the treatment of alcoholism. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:17 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Carbamazepine; Depression; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Secondary Prevention; Taurine; Topiramate	2006
The pharmacological treatment of alcohol dependence. Medicine and health, Rhode Island, 1997, Volume: 80, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depression; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Taurine	1997
Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Depression; Female; gamma-Glutamyltransferase; Humans; Male; Naltrexone; Narcotic Antagonists; Placebos; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Taurine; Treatment Outcome	2001

Trials

3 trial(s) available for acamprosate and Depression

Article	Year
Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcoholism, clinical and experimental research, 2012, Volume: 36, Issue:3 Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior, Addictive; Bipolar Disorder; Depression; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Markov Chains; Middle Aged; Psychiatric Status Rating Scales; Taurine	2012
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. European addiction research, 2005, Volume: 11, Issue:2 Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Anxiety Disorders; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotics; Predictive Value of Tests; Prospective Studies; Secondary Prevention; Somatoform Disorders; Surveys and Questionnaires; Taurine; Treatment Outcome	2005
Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Depression; Female; gamma-Glutamyltransferase; Humans; Male; Naltrexone; Narcotic Antagonists; Placebos; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Taurine; Treatment Outcome	2001

Other Studies

2 other study(ies) available for acamprosate and Depression

Article	Year
Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice. Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:7 Topics: Acamprosate; Alcohol Drinking; Animals; Anxiety; Citalopram; Depression; Drug Therapy, Combination; Male; Mice; Stress, Psychological; Taurine	2016
Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Oct-01, Volume: 39, Issue:1 Topics: Acamprosate; Animals; Antidepressive Agents; Benzamides; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Pyrazoles; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Taurine	2012

Article

Year

Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice.

Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:7

Topics: Acamprosate; Alcohol Drinking; Animals; Anxiety; Citalopram; Depression; Drug Therapy, Combination; Male; Mice; Stress, Psychological; Taurine

2016

Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.

Progress in neuro-psychopharmacology & biological psychiatry, 2012, Oct-01, Volume: 39, Issue:1

Topics: Acamprosate; Animals; Antidepressive Agents; Benzamides; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Pyrazoles; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Taurine

2012